Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Features

Analysis: Slow and steady does it in the first quarter
The first quarter of 2019 may not have broken records, but it puts the year on track for a solid performance after the historic successes of the previous 12 months.
Changing attitudes – sustainability, nutrition and wellness
Perspectives on sustainability and wellbeing are changing in response to health and environmental challenges, offering an opportunity to university-linked businesses.
How to change the world for the better
Anne Dobrée, head of Cambridge Enterprise Seed Funds, talks to editor Thierry Heles about the unit’s work and the evolution of university venturing over the past two decades.
Israel goes from startup to scale-up nation
Innovative Region: Israel
Investing in Israeli companies
Jonathan Tudor, director of Centrica Innovations, was in Israel for the GCV Israel conference, Israel’s first corporate venturing conference, and to launch a £100m Centrica Innovations fund.
Dare to fail greatly
March issue editorial by editor Thierry Heles.
Innovation communications: campus, cluster and country
Gregg Bayes-Brown, OUI’s communications manager, shares his thoughts on the drivers and strategies surrounding the communication of university innovation.
Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.

News Continued

Big deal: Anaveon proves UZH fund model works
Anaveon emerged out of University of Zurich in late 2017 with the support of Novartis-backed UZH Life Sciences Fund and the corporate has now also invested directly.
Big deal: Nightstar shines bright in $800m acquisition
Nightstar Therapeutics, based on Oxford research, stands to receive $800m from Biogen in an acquisition deal that comes a year and a half after completing a $75m IPO.
War on cancer – is the end in sight?
GUV reporter Callum Cyrus takes an in-depth look at oncology spinouts four years after Global University Venturing first looked at the sector in detail, and finds there is much to be optimistic about.
UC entrepreneur startup showcase
Event review: University of California Entrepreneur (UC) Startup Showcase
Holding hands with the entrepreneurs of tomorrow
Editor Thierry Heles reports from Autm’s annual meeting in Austin, Texas
I license, therefore I am
February 2019 issue editorial by editor Thierry Heles

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Holding hands with the entrepreneurs of tomorrow
Editor Thierry Heles reports from Autm’s annual meeting in Austin, Texas
Redefining university innovation in the 21st century: Part 1
Christine Gulbranson, chief innovation officer of University of California, outlines the changes her institution has enacted to support the innovation ecosystem.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
test reg

Login